PubMed HealthSearch

Biomedical subjects

G Cordis

Publications and source records attributed to G Cordis.

3 recordsLinked to original sources

Ischemic preconditioning triggers phospholipase D signaling in rat heart.

Recent studies have indicated that repeated brief episodes of ischemia and reperfusion render the myocardium more tolerant to subsequent lethal ischemic injury. In view of the previous observations that ischemia-reperfusion potentiates phospholipase D signaling and that such signaling is beneficial for the heart, we investigated whether a similar phospholipase D signaling is responsible for the beneficial effects associated with repeated ischemia and reperfusion. Using an isolated perfused working rat heart model, we demonstrated that four brief episodes of 5 min of ischemia and 10 min of reperfusion reduced the incidence of ventricular arrhythmias, enhanced the postischemic ventricular performance, and decreased the release of creatine kinase from the reperfused heart, with simultaneous activation of phospholipase D generating the second messengers diacylglycerol and phosphatidic acid and leading to the translocation and activation of protein kinase C. The specific antiphospholipase D antibody blocked the activation of phospholipase D and attenuated the generation of diacylglycerol and phosphatidic acid and activation of protein kinase C. In concert, phospholipase D inhibition increased the incidence of ventricular arrhythmias, blocked the beneficial effects of preconditioning on the ventricular performance, and increased the amount of creatine kinase release from the coronary effluent. The results of this study indicate that repeated brief episodes of ischemia and reperfusion exert beneficial effects on the intact rat heart by triggering the activation of a phospholipase D signaling mechanism.

Animals

Identification and characterization of plasmalogen fatty acids in swine heart.

Reperfusion of ischemic swine myocardium is associated with the loss of sarcolemmal phospholipids resulting in the accumulation of amphiphilic metabolites, lysophosphoglycerides and free fatty acids, especially arachidonic acid, causing electro-physiological dysfunction and cell death. Recently, phospholipids containing a vinyl ether bond at the Sn-1 position, commonly known as plasmalogens, have been identified as major constituents of heart, which contain a large amount of arachidonic acid in the Sn-2 position. Because of the potential importance of plasmalogens, the fatty acid composition of the choline and ethanolamine phosphoglycerides in swine heart was determined. Lipids were extracted from the left ventricular biopsies from swine heart, phosphoglycerides were separated from the neutral lipids by thin layer chromatography, converted into methyl derivatives and analysed by GC. The peaks for fatty acid methyl ester (FAME) and dimethylacetal (DMA) derivatives of choline and ethanolamine phosphoglycerides were confirmed using GC-MS. The results showed high amounts of 18:1 (17 mol%), 18:2 (24 mol %) FAME in choline phosphoglycerides in contrast to the occurrence of a high amount of 20:4 (28 mol%) FAME in ethanolamine phosphoglycerides, suggesting that plasmenylethanolamine, and not plasmenylcholine, may serve as the depot for arachidonic acid in swine heart.

Animals